Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Land and Mineral Rights
QFR217385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
4,946.00
Year-over-Year Change
1.04%
Date Range
10/1/2000 - 1/1/2025
Summary
This trend tracks the financial reporting of land and mineral rights within the U.S. pharmaceutical and medicines sector. It provides critical insights into corporate asset valuation and strategic resource management in a key industry segment.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The data represents the quarterly financial accounting of land and mineral rights held by pharmaceutical corporations, reflecting potential long-term investment strategies and asset portfolio compositions. Economists analyze this metric to understand corporate resource allocation and potential future development capabilities.
Methodology
Data is collected through mandatory quarterly financial reporting by publicly traded pharmaceutical corporations, compiled and standardized by federal economic research agencies.
Historical Context
This trend is used in macroeconomic analysis to assess corporate asset strategies, potential resource development, and sector-specific investment patterns.
Key Facts
- Tracks quarterly land and mineral rights for pharmaceutical corporations
- Provides insights into corporate resource management strategies
- Part of comprehensive financial reporting for publicly traded companies
FAQs
Q: What does this economic trend measure?
A: It measures the financial reporting of land and mineral rights within the U.S. pharmaceutical and medicines sector, tracking corporate asset holdings.
Q: Why are land and mineral rights important for pharmaceutical companies?
A: These rights can represent potential future research facilities, resource development sites, or strategic long-term investments for pharmaceutical corporations.
Q: How often is this data updated?
A: The data is updated quarterly, providing a consistent snapshot of corporate asset management in the pharmaceutical sector.
Q: How do economists use this trend?
A: Economists analyze this trend to understand corporate investment strategies, sector-specific resource allocation, and potential future development capabilities.
Q: What are the limitations of this data?
A: The data only covers publicly traded pharmaceutical corporations and represents a specific moment in time, which may not reflect entire industry dynamics.
Related Trends
Quarterly Financial Report: U.S. Corporations: Wholesale Trade, Durable Goods: Land and Mineral Rights
QFR217421USNO
Quarterly Financial Report: U.S. Corporations: Electrical Equipment, Appliances, and Components: Long-Term Debt, Due in More Than 1 Year: Other Long-Term Loans
QFRD319335USNO
Quarterly Financial Report: U.S. Corporations: Plastics and Rubber Products: Inventories
QFR214326USNO
Quarterly Financial Report: U.S. Corporations: Wholesale Trade, Nondurable Goods: Land and Mineral Rights
QFR217422USNO
Quarterly Financial Report: U.S. Corporations: Primary Metals: Other Short-Term Financial Investments
QFRD210PRIUSNO
Quarterly Financial Report: U.S. Corporations: All Manufacturing: Cash Dividends Charged to Retained Earnings This Quarter
QFR120MFGUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Land and Mineral Rights [QFR217385USNO], retrieved from FRED.
Last Checked: 8/1/2025